Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 13 de 13
Recenti Prog Med ; 112(7): 499-503, 2021.
Article in Italian | MEDLINE | ID: covidwho-1311322


Access to vaccines against covid-19 is a very topical issue. On the one hand, we are suffering from supply problems and inadequate availability of doses both nationally and internationally. On the other hand, public health needs do not coincide with those of the market economy: the need to vaccinate the entire world population to overcome the pandemic cannot be satisfied due to market rules and limits in production processes. The result is a radical inequality in access to vaccines. We are aware of the delicate balance between health and economy: the latter cannot ignore the former. Also for this reason, the demand for greater equity in access to vaccines is growing: the race for innovation may not be hindered by a targeted relaxation of the rules on intellectual property during a pandemic health emergency.

COVID-19 Vaccines/supply & distribution , COVID-19/prevention & control , Drug Development , Intellectual Property , Biomedical Research/economics , COVID-19 Vaccines/economics , Diffusion of Innovation , Global Health , Healthcare Disparities , Humans , Italy , Needs Assessment , Patents as Topic , Public Health , Research Support as Topic/economics , Vaccination Coverage
Sci Transl Med ; 13(584)2021 03 10.
Article in English | MEDLINE | ID: covidwho-1127538


The COVID-19 pandemic halted research operations at academic medical centers. This shutdown has adversely affected research infrastructure, the current research workforce, and the research pipeline. We discuss the impact of the pandemic on overall research operations, examine its disproportionate effect on underrepresented minority researchers, and provide concrete strategies to reverse these losses.

Academic Medical Centers , COVID-19/epidemiology , Career Choice , Pandemics , SARS-CoV-2/physiology , Biomedical Research/economics , Humans , Minority Groups , Research Support as Topic/economics
Cell ; 183(3): 576-579, 2020 10 29.
Article in English | MEDLINE | ID: covidwho-1023491


To manifest our sincerest aspirations to "enhance health, lengthen life, and reduce illness and disability," the US biomedical research enterprise must directly confront the reality of structural racism in scientific funding and the widespread denial of its existence. I believe that moment in American history has, at long last, arrived.

Racism , Research Support as Topic/economics , Biomedical Research/economics , Cultural Diversity , Humans , National Institutes of Health (U.S.) , Research Personnel , United States